Human mesenchymal stem cells (hMSC) are being administered by direct intramyocardial (IM) injection into patients with myocardial dysfunction with an objective to improve clinical status. However, surprisingly little attention has been directed to qualifying hMSC functionality beyond simple viability. In particular, the transit of hMSCs through a small-caliber needle lumen, the final fluidic pathway for all IM injection devices, may be especially prone to inducing unwarranted effects on cell function. This study evaluated the changes in clonogenicity, gene expression, and cytokine secretion that may be induced in hMSC (20 million/ml) by injection through a 26-gauge Nitinol needle at two different flow rates compared to noninjected control samples. Results indicated that hMSC viability and colony forming unit (CFU) formation was not altered by changes in injection rate, although a trend toward lower titers was noted at the higher flow rate, for the specific batch of hMSCs studied. The gene expression and cytokine analysis data suggest that delivering a suspension of MSCs through narrow lumen needles may marginally alter certain gene expression programs, but that such in vitro effects are transient and not translated into measurable differences in protein production. Gene expression levels of four cytokines (bFGF, SDF-1, SCF, VEGF) were significantly different at 400 µl/min, and that of all cytokines were significantly different at 1600 µl/min when compared to controls (p < 0.05). These changes were less pronounced (statistically insignificant for most cases, p > 0.05) and, in certain instances directionally opposite, at 72 h. However, no differences in the amounts of secreted bFGF, VEGF, or TGF-β were detectable at either of the two time points or flow rates. We infer that intramyocardial administration by transcatheter techniques is unlikely to interfere with the machinery required for cell replication or secretion of regulatory and other growth factors, which are the mainstays of MSC contribution to cardiac tissue repair and regeneration.
INTRODUCTION
lion (43), fulfilling the definition of a chronic epidemic. While advances in contemporary medical and surgical therapy improve the quality and duration of lives of many The leading cause of death in the US is heart disease (22) , with ischemic processes constituting the predomi-patients, each has its shortcomings, leading to a great deal of interest in cell-based therapies. nant pathogenic mechanism. A continuum of ischemic disease exists, initiated by acute infarction and perpetu-A variety of cell types have been utilized for cardiovascular repair (61), including autologous bone marrow ated both by additional ischemic insults and chronic changes in left ventricular geometry, bringing patients mononuclear cells (60) and their subpopulations (2,11, 52), autologous skeletal myoblasts (28) , endothelial pro-to progressive left ventricular systolic dysfunction and the syndrome of congestive heart failure (8). When the genitor cells (27) , as well as allogeneic mesenchymal stem cells from various sources (3). Mesenchymal stems 300,000 newly diagnosed cases of postinfarction congestive heart failure are added to the all-cause pool, the cells (MSCs) hold a special role in regenerative medicine, in light of characteristics specific to this popula-US prevalence of patients' CHF is a staggering 5.2 mil-tion: they are multipotent (39) , immunomodulatory (15) , effect(s) on their biological and physiological function. Under sustained fluid flow, shear stress of 1-15 dyn/ and easily expanded in culture (21) . Derived from healthy donors and able to circumvent the effects of age and cm 2 on attached MSCs has been shown to selectively upregulate the mitogen activated protein kinase (MAPK) disease on potency (unlike autologous cells) (12, 25) , they are a readily available "off the shelf" product. Ex-signaling pathway (10), increase smooth muscle myosin heavy chain expression (18) , and induce expression of perience thus far indicates that bone marrow-derived MSCs are capable of either reversing or attenuating endothelial cell markers such as CD31, von Willebrand Factor and VE-cadherin (53) . While the levels of shear postinfarction systolic left ventricular dysfunction (63) . The transplanted MSCs secrete a variety of cytokines stress may be substantially higher than 15 dyn/cm 2 during transit of freely suspended MSCs through injection and growth factors that have both paracrine and autocrine activities. These secreted bioactive factors sup-catheters, the duration of exposure is considerably shorter.
In this study we sought to assess the response of hu-press the local immune system, inhibit fibrosis (scar formation) and apoptosis, enhance angiogenesis, and man MSCs (hMSCs) to transcatheter flow. Viability, titer, clonogenicity, gene expression profile, and cytokine se-stimulate mitosis and differentiation of tissue-intrinsic reparative or stem cells. These effects, which are re-cretion were measured following exposure of a fixed concentration of hMSCs to variable flow rates. An ad-ferred to as trophic effects, are distinct from the direct differentiation of MSCs into repair tissue (9). justable flow device was used to drive cell suspensions through a catheter length needle, at rates equal to or A variety of methods for delivering stem cells to the heart have been devised, each utilized, in part, according greater than those employed in preclinical or clinical studies. Quantitative assays of parameters in each of the to the nature of the underlying disease. In the setting of acute myocardial infarction, intravascular infusion has four categories were conducted on pre-and postinjection hMSCs. been found to be a safe and convenient method (16) , making use of migratory responses of progenitor cells
MATERIALS AND METHODS in response to cytokines and regulatory growth factors
Overall Design released at the time of acute injury (19, 57) . However,
In this study, a 20 million/ml suspension of hMSCs in the setting of chronic myocardial disease, where the was driven at two different flow rates (400 and 1600 microenvironment is devoid of active stimuli to promote µl/min) through a transfemoral length 26-gauge Nitinol cell migration, direct intramyocardial injection has gained needle (406 µm OD, 254 µm ID, 155 cm in length). prominence as the primary strategy for cell delivery. The
The study was composed of three sets of experifamily of intramyocardial injection methods approaches ments, each designed to evaluate specific components of the left ventricular wall either via its endocardial or epi-hMSC function: i) cell recovery and viability; ii) clonocardial surface. Common to the design of devices of all genicity, and iii) gene expression and cytokine secretion. methods is their utilization of an injection (core) lumen Separate transcatheter hMSC flow runs were conducted for cell transport. However, specifications vary as to for each of the above assessments. As noted below, to length and caliber of the core lumen. The catheter-based minimize interprocedure variability, key aspects in each systems used percutaneously are, of course, of greater experiment were held constant where possible, including length and have fluidic characteristics very different cell dose and concentration, catheter preparation, prespecithan their shorter syringe needle counterparts used for fied flow rates, and ambient conditions. direct epicardial injections during surgery. The common ranges of needle diameters and lengths have been de-Cell Preparation scribed previously (34, 45, 46) . A review (45) and analy-Cryopreserved bone marrow-derived hMSCs at passis (46) of currently available intramyocardial injection sage 5 (Lonza Inc., Walkersville, MD, Batch No. systems have been published. Direct intramyocardial in-6F4382) were thawed and cultured through two addijections have been applied to patients with refractory tional passages (P7). Cells were trypsinized and reconangina, CHF due to chronic systolic left ventricular dysstituted in Dulbecco's phosphate buffered saline (PBS) function (6), and, more recently, in the early post-MI to a concentration of ϳ2.0 × 10 7 cells/ml, for all experisetting (33) .
ments of this study. The cell suspension was measured Given their proclivity to intravascular aggregation to be of constant viscosity (8.12 cp) using a cone and and microvascular obstruction (and microinfarction), inplate viscometer (Brookefield) and to have a density of tramyocardial injections have been favored for delivery 1.08 g/cc. of MSCs. It is likely that this property of MSCs is opera-Transcatheter Flow Set-Up tive within the core lumens of intramyocardial catheters. What remains unanswered, however, is whether shear E beam sterilized 26-gauge Nitinol (nickel-titanium alloy) needles (Abbott Vascular Inc., Santa Clara, CA) forces imparted to MSCs during transit result in adverse were used for all experiments. Each needle met the fol-ing collection. Using a six-well plate, cell suspensions from the three groups (control, 400 or 1600 µl/min) at lowing specifications: 406 µm OD, 254 µm ID, 155 cm length. Prior to each cell injection, the needle was either 24 h (n = 2 per group) or 72 h (n = 3 per group) were seeded at 2.0 × 10 5 cells per well and maintained flushed with 1 ml saline and air dried. Individual injections were performed using a 1-ml syringe (Becton in basal medium (Lonza) at 37°C. Prior to cell lysis, supernatants were removed and stored at −80°C for sub-Dickenson, Franklin Lakes, NJ), loaded with 300 µl of suspended hMSCs (ϳ20 million cells/ml) and attached sequent cytokine assays (below). Cells were then lysed using a commercially available method (QuantiGene to an infusion pump (PHD 22/2000, Harvard Apparatus Inc., Holliston, MA). The entire volume was then ad-2.0 Sample Processing Kit, Panomics, Fremont, CA) according to the manufacturer's instructions. Expression vanced through the needle at a constant flow rate, leading to the collection of the 150-µl study sample at the levels of a panel of 17 gene markers associated with shear stress, MSC phenotype (56) , secreted cytokines, and distal needle tip. The 150 µl remaining within the needle's "dead-space" was expelled with compressed air be-growth factors (Table 1) in the cell lysates were then determined using the Quantigene Plex 2.0 Reagent fore the next syringe containing the second sample of 300 µl was attached. This latter cycle was repeated two Assay (Panomics). This technique combines branched DNA (bDNA) signal amplification and multianalyte additional times, resulting in three samples (n = 3) collected for each specific group of experiments. Separate profiling bead technologies to enable the detection and simultaneous quantification of multiple mRNA targets runs were conducted at two flow rates (400 or 1600 µl/ min). A control group for each flow experiment was cre-directly from cell lysates (55). Each sample was assayed in triplicate. Background fluorescence (measured in ated by collecting hMSC samples directly from the 1-ml injection syringe, without needle passage. A total of six RNA-free samples) was subtracted from RNA-containing samples. Each gene marker was then normalized to a separate flow experiments were conducted to generate an amount of study samples (n = 18) sufficient for bio-constitutively and ubiquitously expressed housekeeping gene, β-actin (ACTB), a nonmuscle cytoskeletal actin assay. All flow studies were performed at room temperature.
that is involved in the regulation of cell motility, structure, and integrity (14, 23, (29) (30) (31) (32) . Normalized values Cell Viability and Recovery were expressed as relative light units (RLUs) and aver-The eluted hMSC suspensions from the three groups aged for each treatment group. Expression of a second (control, 400 and 1600 µl/min) were diluted 20 times in housekeeping gene for the protein folding enzyme pepti-PBS in preparation for cell viability analysis by the trydylprolyl isomerase B (cyclophilin B) (PPIB) was meapan blue exclusion method, utilizing an automated cell sured with reference to ACTB. counter (Vi-CELL XR analyzer, Beckman Coulter Inc., Fullerton, CA). For each group, three replicate readings Cytokine Analysis were performed. In addition to percentage viability, total Concentrations of VEGF, bFGF, and active TGF-β and viable cell numbers were also obtained, from which secreted were measured from the collected supernatant the percent cell recovery was calculated. samples using the Procarta Cytokine ELISA Assay Kit, (Panomics Inc.) following manufacturer's instruc-Colony Forming Unit (CFU) Assay tions. Briefly, cytokine assessment with this ELISA Clonogenicity was assessed using a CFU assay (40).
method employs the addition of antibodies to multiana-Samples were diluted with PBS to 1.0 × 10 5 cells/ml, lyte profiling beads. Data (with the background value and 3 × 5-µl aliquots (500 cells/well or 50 cells/cm 2 ) subtracted) were averaged to compare cytokine expresfrom each group were seeded into each well of a sixsion across treatment groups. well culture dish (ϳ10 cm 2 per well). After 6 days of culture, followed by fixation in 100% methanol at 4°C, Data Analysis and staining in crystal violet solution (2.3% w/v) at There were three replicates for each group in each room temperature, the excess dye was washed off with experimental set, except for the ELISA and gene expresdeionized H 2 O, and the six-well dishes air dried. The sion data at the 24-h time point where there were only cells within discrete colonies were stained purple, and two replicates (due to limited availability of samples). were observed and counted under bright-field micros-
The results from each data set were expressed as mean ± copy. Only colonies with more than 30 cells were coun-SD. For cell viability, recovery, and CFU assay, differted in each well. ences between data sets were assessed by single factor Gene Expression ANOVA with p < 0.05 considered significantly different. Differences in gene expression and cytokine produc-To evaluate time-related changes in hMSC gene expression, assays were conducted at 24 and 72 h follow-tion were determined for statistical significance using These can be broadly divided into three categories: (i) markers associated with MSC phenotype, (ii) markers associated with shear stress, and (iii) cytokines and growth factors known to be secreted by MSC.
ANOVA followed by multiple comparison Holm's t-test tion of viable cells within the recovered population was not different between groups (p = 0.18). (p < 0.05). Markers with statistically significant changes were considered biologically significant if there was Colony Forming Unit (CFU) Capacity greater than twofold change over control.
The results of the CFU assay demonstrated that there RESULTS were no significant differences in the proliferative capacity and clonogenicity of MSC between the groups As noted previously, transcatheter flow rates of 400 and 1600 µl/min were chosen to simulate relevant proto-(p = 0.58). There were 12.0 ± 1.0 colonies per well formed at a flow rate of 400 µl/min, 12.3 ± 0.6 colonies cols and a fourfold higher bound, respectively. From the control and two flow rate groups, three samples were per well at 1600 µl/min, and 11.7 ± 0.6 colonies per well in the control group. In all groups, only colonies with obtained for each functional assessment. Due to a technical issue, 24-h gene expression analysis and cytokine more than 30 cells per colony were counted. production was conducted in only two samples.
Gene Expression Cell Viability and Recovery
Gene expression results are shown in Table 2 , with the 17 gene markers at both 24 and 72 h expressed as hMSC viability was high in both flow groups: 94.2 ± 0.4% at 400 µl/min, 93.8 ± 0.8% at 1600 µl/min), and RLUs after normalization to ACTB. Although some intracellular signaling responses to mechanical stimuli can not significantly different from control (94.4 ± 2.3%, p = 0.87). Cell recovery, defined as the ratio of effluent to occur rapidly within seconds or minutes (e.g., ion permeability), the 24-and 72-h time points for marker ex-injected (control) cell titers, trended inversely with catheter flow rate. Cell titers fell as flow increased, leading pression were chosen because altered gene expression develops over several hours (35) . Changes in values in to recovery rates of 88.2 ± 7.8% and 77.9 ± 16.7% for 400 and 1600 µl/min, respectively (p = 0.19). The frac-the table were obtained by normalizing the 400 or 1600 
6.71 ± 0.37 (×10 −1 ) 6.32 ± 0.35 (×10 −1 ) −6 6.57 ± 0.28 (×10 −1 ) −2 3.20 ± 0.17 (×10 −1 ) 3.56 ± 0.15 (×10 −1 )* +11 2.82 ± 0.05 (×10 −1 )* −13 CD44
1.21 ± 0.10 4.15 ± 0.03 (×10 −1 ) 4.08 ± 0.18 (×10 −1 ) −2 3.81 ± 0.00 (×10 −1 )* −9 8.01 ± 0.81 (×10 −2 ) 7.70 ± 0.49 (×10 −2 ) −4 6.59 ± 0.76 (×10 −2 ) −22 bFGF 6.43 ± 0.05 (×10 −2 ) 7.77 ± 0.04 (×10 −2 )* +21 9.38 ± 0.24 (×10 −2 )* +46 7.73 ± 0.04 (×10 −2 ) 8.46 ± 0.07 (×10 −2 )* +9 7.30 ± 0.03 (×10 −2 )* −6 SDF-1 1.89 ± 0.00 (×10 −1 ) 1.39 ± 0.14 (×10 −1 )* −36 1.59 ± 0.04 (×10 −1 )* −19 1.15 ± 0.06 (×10 −1 ) 1.38 ± 0.04 (×10 −1 )* +11 1.08 ± 0.11 (×10 −1 ) −6 SCF 1.31 ± 0.02 (×10 −1 ) 1.18 ± 0.01 (×10 −1 )* −11 1.40 ± 0.05 (×10 −1 )* +7 3.65 ± 0.71 (×10 −2 ) 3.76 ± 0.18 (×10 −2 ) +3 2.37 ± 0.33 (×10 −2 )* −54 VEGF 1.87 ± 0.06 (×10 −1 ) 3.24 ± 0.07 (×10 −1 )* +73 2.45 ± 0.06 (×10 −1 )* +31 7.08 ± 0.52 (×10 −2 ) 7.28 ± 0.06 (×10 −2 ) +3 5.53 ± 0.75 (×10 −2 )* −28 Housekeeping marker PPIB 7.91 ± 0.55 (×10 −1 ) 6.76 ± 0.11 (×10 −1 ) −16 7.38 ± 0.77 (×10 −1 ) −8 4.27 ± 0.13 (×10 −1 ) 4.20 ± 0.08 (×10 −1 ) −2 3.88 ± 0.14 (×10 −1 )* −10 
µl/min flow group values to the time-matched control
There was no statistical difference in TGF-β1, VEGF, or bFGF secretion at either flow rate compared to controls, group values. Expression of a second housekeeping gene, PPIB, a ubiquitous enzyme involved in protein irrespective of the time at which these factors were measured. This is at variance with gene expression findings, folding, and its subsequent normalization to ACTB revealed that the level of housekeeping gene expression in which a 73% increase plus in VEGF transcription was observed. Secretion by hMSCs of IGF-1, in which an was similar across all treatment groups at both time points (<16% differences).
81% increase in gene expression was seen (Table 2) , was not assayed in this study. As displayed in Table 2 , statistically significant changes in expression were noted among various gene DISCUSSION markers related to phenotype, shear stress, and cytokine production. However, there were no biologically signifi-Bone marrow-derived MSCs are relatively abundant and easy to isolate, have high proliferative capacity, pos-cant changes in marker expression, as all markers exhibited less than twofold change over control. When mea-sess multilineage differentiation potential (44, 51) , and, therefore, regenerative potential. As allogeneic cells, sured 24 h after injection, reductions in CD90 and CD146 were induced by flow rates of 400 µl/min, but they provide a treatment option that circumvents the need for preprocedural cell harvesting from the patient. not at 1600 µl/min. Other MSC phenotypic markers (CD13, CD29, CD44, CD105, and CD166) remained
MSCs have been effective in treating both the acutely and chronically infarcted myocardium (1, 4, 17, 24, 29, 38) , unchanged at 24 h. At 72 h, expression levels of all markers in this category (excepting CD90 and CD146) but, because of their size and tendency to aggregate, are known to impede blood flow after intracoronary infusion increased significantly in response to 400 µl/min flow compared to controls, especially CD13 (+49%). How-and thus are best administered by intramyocardial or, perhaps, by retrograde coronary venous injection. ever, exposure to 1600 µl/min flow resulted in a near uniform reduction in expression of these markers.
To understand the fluid dynamics and the shear forces at play in the transcatheter environment, we eval-Of the two shear stress markers assayed, only VCAM-1 demonstrated any change, falling at 24 h by uated the passage of a suspension of ϳ20 million hMSCs/ ml through a Nitinol needle (406 µm OD, 254 µm ID, 25% in response to 400 µl/min of flow. No differences at 72 h were noted in VCAM-1 or ICAM-1 at either 155 cm in length) at two different flow rates (400 and 1600 µl/min), the former comparable to those used in flow rate, suggesting a minimal effect upon markers known to be sensitive to shear stress conditions (20, clinical studies. Such flow rates (and their corresponding shear stresses) are of concern, as they exceed levels re-31,53).
Of the six genes that mark cytokine production, two ported to effect cell behavior (20, 31, 53) . Figure 1 is a conceptual representation that elucidates the flow pat-rose (bFGF and VEGF), two decreased (SDF-1 and SCF), and two did not change (IGF-1 and TGF-β) at 24 terns and associated stresses on a single cell with respect to the fluid it is suspended in, through a narrow lumen h after exposure to the lower flow rate. Of these, VEGF experienced the largest change (+73%). At 1600 µl/min needle. We first confirmed that a suspension of ϳ20 hMSCs/ml behave like a Newtonian fluid (data not flow, the expression of all secreted cytokine genes significantly changed, greatest observed in IGF-1 (+81%), shown). Transneedle flow was confirmed to be laminar from previously derived models (7), with a Reynolds with lesser differences noted in bFGF (+46%) and VEGF (+31%). However, at 72 h after transcatheter number (Re) ϳ4.5 at 400 µl/min and ϳ18 at 1600 µl/ min (data not shown), well below the transitional level flow, fewer significant differences were observed compared to control, most notably a reduction in SDF of (Re = 2100) to turbulence. Other concentrations of hMSC suspensions were not tested. 54% in the 1600 µl/min group.
In all, the effects of flow rate on gene expression In our model, because the calculated average flow velocity (flow rate/cross-sectional area) was ϳ13.6 cm/ were varied, bidirectional, and small, with changes generally less than 1.5-fold. Of note, expression of s at 400 µl/min and ϳ54.3 cm/s at 1600 µl/min, the average transit time per cell was 11.4 and 2.85 s, respec-PECAM-1 and VE-cadherin, both markers expressed by endothelial cells, were found to be at background levels tively. Given that flow is laminar (1 < Re << 2100) at both flow rates, the velocity profile is parabolic; the for all treatment groups at both time points (data not shown), suggesting that the treatment conditions of this shear is maximal at the needle wall, zero at the center line, and changes linearly with distance between the two study resulted in minimal MSC differentiation along an endothelial lineage pathway.
( Fig. 1a) (7) . Therefore, each cell flowing along a streamline is exposed to two shear stresses: the higher Cytokine Secretion one nearer to the needle wall and the lower nearer the center of the lumen. The resultant shear stress on the The levels of bFGF, VEGF, and TGF-β found in hMSC supernatants of all groups are shown in Table 3 .
cell (τ rz cell) is therefore the difference of these two forces and as shown in Figure 1b . Using an hMSC sus-µl/min, respectively. The resultant shear stresses on the cell were calculated to be 50.83 and 203.2 dyn/cm 2 , both pension viscosity of 8.12 cp (µ), a needle radius of 125 µm (R), and a mean cell diameter of 18 µm (d), the significantly higher than the range (1-46 dyn/cm2) observed in previous reports to influence cells (20, 31, 53) . maximum shear stresses τ rz max at the wall of the needle were estimated (using equation in Fig. 1b ) to be ϳ353
The effects of shear rates of this magnitude have not been reported to date. While the transient exposure of and 1411 dyn/cm 2 at a flow rates (Q) of 400 and 1600 (44) . The shear stress τ rz is zero at the center and increases linearly to its maximum value at the wall. (b) A single cell of diameter d flowing long any fluid streamline through the needle would experience a higher shear stress on the side closer to the wall than on the inner side. The net shear stress on the cell (τ rz cell) is hypothesized to be the difference between these two forces.
freely suspended hMSCs as reported in our study is fun-any of the MSC phenotype markers examined at either time point or flow rate. Additionally, the effects on shear damentally different from the earlier reports of longer durations of exposure caused by the flow of liquid past stress markers were investigated. Previous studies on attached endothelial cells have reported a 17-fold increase attached cells on a rotating disc, our experimental conditions are similar to the conditions commonly employed in PECAM-1 expression after 6 h of exposure to 15 dyn/ cm 2 shear stress (53), a 270-fold increase in VE-cadherin in clinical studies.
Release criteria applied to cell preparations for inves-expression after 24 h of 15 dyn/cm 2 shear stress (53), a 40-75% decrease in VCAM-1 expression after 6 h of tigational use do not include measures reflecting the subtle changes in cell function that might be incurred by 3-15 dyn/cm 2 shear stress (20) , and a 2.77-fold increase in ICAM-1 expression after 48 h of 10 dyn/cm 2 shear sublysis levels of shear. Cell viability assays, such as trypan blue exclusion, that rely upon the membrane in-stress (31). It is important to note that these groups found the gene expression changes in response to shear tegrity are a useful primary indicator of potential damage to a cell. However, given the transient time of ex-stress to be time dependent, force dependent, and reversible. Although the current experimental design created posure to high shear forces in our model, membrane integrity as measured by trypan blue exclusion assay is higher shear stress levels (353-1411 dyn/cm 2 ) over a shorter period of time (ϳ3-12 s), MSCs demonstrated unlikely to uncover delayed apoptotic responses triggered at the molecular level. Hence, further investigation no biologically relevant fluctuation in the expression of PECAM-1, VCAM-1, and ICAM-1, shear stress markers into the proliferative capacity, phenotypic and genotypic expressions, and cytokine excretion of hMSCs was un-reportedly affected in other cell types (20, 31, 53) . Finally, transcriptional-level expression of secreted growth dertaken, the last to determine whether transcriptionlevel changes, if any, translated to altered protein secre-factors and cytokines involved in angiogenesis, cell survival, recruitment, and differentiation were also unaffected tion.
The results of this study clearly demonstrate that nei-by passage through the catheter. The MAPK signaling pathway is often involved in a variety of ubiquitous pro-ther cell viability assessed by trypan blue exclusion, nor proliferative capacity and clonogenicity assessed by cesses (50). Others have reported that the MAPK gene ERK1/2, but not p38 or JNK, is upregulated in endothe-CFU assay, show any significant changes with either flow rate of 400 or 1600 µl/min. Furthermore, no signif-lial cells after 10 min of shear stress at 15 dyn/cm 2 (26, 49) . Additionally, reports indicate that the MAPK icant decreases in cell titer were seen. There was a trend toward reduced cell recovery at the higher flow rate (no-signaling pathway both influences and is influenced by shear stress-induced genes, such as PECAM-1 (54,58). table for its large standard deviations in both flow groups). Reductions in cell count of this nature may be Because the current experimental system encompasses a high shear stress environment with a short duration of due to aggregation seen at high MSC titers (13) and to adhesion along the inner surface of the catheter device. exposure and shear stress makers were unaffected, it is uncertain whether MAPK gene expression would have Higher concentration of MSCs (up to 75 million/ml) were investigated (data not shown). The percentage loss been affected in this system. Further, PECAM-1 expression was unchanged in our experiments and at back-was less and seemed to level off with increasing concentrations, perhaps due to the finite number of cells can ground levels. The upregulation in VEGF expression after 24 h in attach to the available inner surface of the fluidic pathway.
the 400 µl/min group represented the greatest significant change observed, and though not a twofold change, Gene markers associated with shear stress, MSC phenotype and secreted cytokines and growth factors, dem-these data would suggest that the clinical relevant flow rate can slightly induce upregulation of marker expres-onstrated no significant differences between experimental groups in the majority of markers. Although the sion related to angiogenesis. These data suggest that while the passage of MSCs through a catheter needle expression of some gene markers displayed statistically significant changes, this is probably due to the low vari-can have small perturbations on multiple growth factor and cytokine gene expression, collectively, the data re-ability of the replicate readings. None of the changes in gene expression levels exceeded 100% (twofold) with veal that passage of MSCs through a Nitinol needle had a minimal effect upon various marker expression at the respect to the control and hence was not considered to be biologically significant. transcriptional level. Although both gene expression and cytokine ELISA MSC phenotype markers were an important component of the investigation due to the need for the stem data suggest that shear forces encountered by MSCs upon passing through the intramyocardial injection cath-cells to maintain their "MSC phenotype" upon injection. The data (Table 2) 
